Cyclezyme AB (XSAT:CYCLE) Total Assets: kr7.98 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CYCLE Cyclezyme AB XSAT:CYCLE
8 GF Score
Price kr24.40
! 3 Warning Signs
View Full Analysis

What is Cyclezyme AB Total Assets?

Cyclezyme AB XSAT:CYCLE +2.09% 8 Total Assets is kr7.98 Mil as of Mar. 2026. GuruFocus rates XSAT:CYCLE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review.

Cyclezyme AB's Total Assets for the quarter that ended in Mar. 2026 was kr7.98 Mil.

During the past 12 months, Cyclezyme AB's average Total Assets Growth Rate was 47.90% per year. During the past 3 years, the average Total Assets Growth Rate was 245.30% per year.

During the past 6 years, Cyclezyme AB's highest 3-Year average Total Assets Growth Rate was 245.30%. The lowest was 207.70%. And the median was 226.50%.

Total Assets is connected with ROA %. Cyclezyme AB's annualized ROA % for the quarter that ended in Mar. 2026 was -40.12%. Total Assets is also linked to Revenue through Asset Turnover. Cyclezyme AB's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Cyclezyme AB  (XSAT:CYCLE) Total Assets Explanation

Total Assets is connected with ROA %.

Cyclezyme AB's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-3.332/( (8.636+7.975)/ 2 )
=-3.332/8.3055
=-40.12 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cyclezyme AB's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (8.636+7.975)/ 2 )
=0/8.3055
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cyclezyme AB Total Assets Related Terms

Cyclezyme AB Total Assets Historical Data

* Premium members only.

The historical data trend for Cyclezyme AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclezyme AB Total Assets Chart

Cyclezyme AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 0.41 2.05 8.15 5.80 8.64

Cyclezyme AB Quarterly Data
Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.53 7.74 7.10 8.64 7.98
XSAT:CYCLE
8GF Score
Cyclezyme AB XSAT:CYCLE
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cyclezyme AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cyclezyme AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=7.75+0.886
=8.64

Cyclezyme AB's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=6.917+1.058
=7.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of kr7.98 Mil mean?
Cyclezyme AB (XSAT:CYCLE) has a Total Assets of kr7.98 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Cyclezyme AB and its competitors.
Is Cyclezyme AB's Total Assets too high?
Cyclezyme AB's current Total Assets is kr7.98 Mil. Overall, Cyclezyme AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's Total Assets compare to LIN and SHW?
Cyclezyme AB's Total Assets of kr7.98 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Chemicals company?
A good Total Assets depends on the Chemicals industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Cyclezyme AB and its competitors. Cyclezyme AB's current Total Assets is kr7.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current Total Assets of kr7.98 Mil. The current Total Assets is kr7.98 Mil. Cyclezyme AB's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current Total Assets is kr7.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyclezyme AB Business Description

Address Scheelevagen 22, Lund, SWE, 223 63
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
8GF Score

Get the complete analysis for XSAT:CYCLE

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr24.40
Price